Revisit Every OncLive On Air Episode From October 2024
In case you missed any, read a recap of every episode of OncLive On Air that aired in October 2024.
Related Articles
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens
Experts in gynecologic oncology highlight multiple practice-altering clinical trial updates presented at ESMO and beyond in ovarian, cervical, and endometrial cancers.
The hallmarks of cancer immune evasion
Cancer cells often evade the host immune system, challenging the effectiveness of immunotherapy. In this comprehensive review, Galassi et al. summarize key mechanisms of immune evasion…
(Z)-endoxifen Reduces MBD, Is Well Tolerated in Premenopausal Women Screened for Breast Cancer
(Z)-endoxifen significantly reduced mammographic breast density and was generally well tolerated in premenopausal women screened for breast cancer.
Regorafenib Provides Modest Survival Benefit in Refractory Advanced Gastric/GEJ Cancer
Regorafenib improved overall survival vs placebo in refractory advanced gastric or gastroesophageal junction cancer.
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer
David S. Miller, MD, discusses key efficacy, safety, and quality-adjusted survival data with selinexor in TP53 wild-type endometrial cancer.
The hallmarks of cancer immune evasion
Cancer cells often evade the host immune system, challenging the effectiveness of immunotherapy. In this comprehensive review, Galassi et al. summarize key mechanisms of immune evasion…
Mapping ctDNA Shedding Differences in GU Cancers With MRD Testing
Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.
Continued Development of RAS Inhibitors Leads the Charge in Pancreatic Cancer Research
Tanios S. Bekaii-Saab, MD, discusses the evolving role of RAS-targeted therapies in pancreatic cancer and where future research in the field may be headed.
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
Fu et al. present a comprehensive analysis of the immune landscape within lung cancer brain metastases spanning different genetic backgrounds and TKI treatment scenarios. They report…
